Cora D. Arthur
Washington University in St. Louis · 100 works · 8,966 citations · h-index 18
Top works
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
- Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses
- Defective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- A critical function for type I interferons in cancer immunoediting
- Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
- Cancer immunoediting by the innate immune system in the absence of adaptive immunity
- Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
- Constitutive shedding of both p55 and p75 murine TNF receptors in vivo
- STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
- High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
- Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads
- Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
- Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis
- Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas
- Cancer immunoediting by the innate immune system in the absence of adaptive immunity (162.3)
- Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry